FDA approves Roche’s Xofluza to prevent flu spreading in familiesThe FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people Share XFDA approves Roche’s Xofluza to prevent flu spreading in familieshttps://pharmaphorum.com/news/fda-approves-roches-xofluza-to-prevent-flu-spreading-in-families/
Roche’s Herceptin/Perjeta combo product nears EU approvalThe EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin Share XRoche’s Herceptin/Perjeta combo product nears EU approvalhttps://pharmaphorum.com/news/roches-herceptin-perjeta-combo-product-nears-eu-approval/
Roche’s Xofluza limits spread of flu virus, says new studyRoche’s new influenza drug Xofluza can dramatically prevent the spread of the virus when used as a preventive Share XRoche’s Xofluza limits spread of flu virus, says new studyhttps://pharmaphorum.com/news/roches-xofluza-limits-spread-of-flu-virus-says-new-study/
Sanofi licenses OTC Tamiflu rights for the US marketSanofi has made a bold play to bolster its consumer health business, licensing non-prescription rights to Roche’s influenza Share XSanofi licenses OTC Tamiflu rights for the US markethttps://pharmaphorum.com/news/sanofi-licenses-otc-tamiflu-rights-for-the-us-market/
